It's our last episode in 2021! This episode we have Dr. Libo Wang and Dr. Jon Harrison on to talk about their new paper in the Annals of Internal Medicine about ultrasound JVP for estimating CVP, validated with right heart catheterization. We also ask them their thoughts on a new meta-analysis looking at metoprolol vs diltiazem for atrial fibrillation with RVR.
We also look at a new large retrospective study of apixaban vs rivaroxaban for stroke prevention, a study looking at reducing sleep interruptions in the hospital, and two new outpatient therapies for COVID-19 infection.
Happy New Year!
Ultrasound JVP for estimating CVP
IV Diltiazem vs Metoprolol for A fib with RVR
Major Ischemic and Hemorrhagic Events in Apixaban vs Rivaroxaban for AF
Reducing Sleep Interruptions in Hospitalized Patients
Early Remdesivir for Outpatient COVID-19
Molnupiravir for Outpatient COVID-19
Music from Uppbeat (free for Creators!):
https://uppbeat.io/t/soundroll/dope
License code: NP8HLP5WKGKXFW2R